Of the three biomarkers, PARP1 was firstly validated as a novel diagnostic marker for HCC, GS is the classic marker for HCC [2, 15, 16], and NDRG1 is identified in HCC previously by our center [17] and other groups [18, 19]. Here, NDRG1 is linked to hepatocellular carcinoma.